Slate Medicines Appoints Kenneth Koblan as CSO
Slate Medicines appointed Kenneth Koblan, PhD, as chief scientific officer while advancing the PACAP/VIP antibody SLTE-1009 for migraine. Koblan brings neuroscience, translational, RNA-therapeutics, and drug-development experience from Vesalius, Sumitomo/Sunovion, Merck, and Alnylam. The effective…
